Mesoblast Limited - American Depositary Shares — Cash Flow (NASDAQ:MESO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -106.68 M-65.78 M-63.27 M-48.46 M-49.95 M — Cash from investing activities -1.65 M-232 K-194 K-97 K120 K — Cash from financing activities 114.47 M-9.87 M74.5 M40.25 M147.34 M — Free cash flow -106.68 M-65.78 M-63.27 M-48.46 M-49.95 M —

News

Mesoblast: The Commercial Proof Is Now Becoming The Investment Thesis (NASDAQ:MESO)

Mesoblast Limited (MESO) Presents at ASX CEO Connect June 2026 - Slideshow (NASDAQ:MESO) 2026-06-04

Mesoblast Limited: A Risk/Reward Story (NASDAQ:MESO)

Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript

Why Mesoblast's Move Into DMD Warrants A Speculative Buy (Upgrade) (NASDAQ:MESO)

Mesoblast H1 FY26 slides: first approved MSC product hits $49M

Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication - Mesoblast (NASDAQ:MESO)

FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain - Mesoblast (NASDAQ:MESO)

Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session - American Express (NYSE:AXP), Bread Finl Hldgs (NYSE:BFH)

Mesoblast stock reaches 52-week high at 21.05 USD

Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales - Mesoblast (NASDAQ:MESO)

Mesoblast announces board leadership changes as company evolves